Patents by Inventor Davide RADZIK

Davide RADZIK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY
    Publication number: 20210267931
    Abstract: Methods of using dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality, articles of manufacture and packages related thereto.
    Type: Application
    Filed: October 8, 2020
    Publication date: September 2, 2021
    Inventors: Davide RADZIK, Martin Van EICKELS, Nacéra HAMDANI, Christophe GAUDIN
  • USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY
    Publication number: 20190046496
    Abstract: Methods of using dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality, articles of manufacture and packages related thereto.
    Type: Application
    Filed: March 7, 2018
    Publication date: February 14, 2019
    Inventors: Davide RADZIK, Martin VAN EICKELS, Nacéra HAMDANI, Christophe GAUDIN
  • USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY
    Publication number: 20170273936
    Abstract: Methods of using dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality, articles of manufacture and packages related thereto.
    Type: Application
    Filed: November 9, 2016
    Publication date: September 28, 2017
    Inventors: Davide RADZIK, Martin VAN EICKELS, Nacera HAMDANI, Christophe GAUDIN
  • USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY
    Publication number: 20150328181
    Abstract: Methods of using dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality, articles of manufacture and packages related thereto.
    Type: Application
    Filed: July 29, 2015
    Publication date: November 19, 2015
    Inventors: Davide RADZIK, Martin VAN EICKELS, Nacera HAMDANI, Christophe GAUDIN
  • Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of morality
    Patent number: 9107900
    Abstract: Methods of using dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality, articles of manufacture and packages related thereto.
    Type: Grant
    Filed: March 19, 2013
    Date of Patent: August 18, 2015
    Assignee: SANOFI
    Inventors: Davide Radzik, Martin Van Eickels, Nacera Hamdani, Christophe Gaudin
  • METHODS FOR REDUCING THE RISK OF AN ADVERSE DRONEDARONE / BETA-BLOCKERS INTERACTION IN A PATIENT SUFFERING FROM ATRIAL FIBRILATION
    Publication number: 20140088189
    Abstract: The disclosure relates to a method for managing the risk of dronedarone/beta-blockers interaction by using dronedarone or pharmaceutically acceptable salts thereof in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL), with a recent episode of AF/AFL and associated cardiovascular risk factors, who are in sinus rhythm or who will be cardioverted to reduce the risk of cardiovascular hospitalization, said patients also expecting to receive a beta-blockers treatment, by performing the following steps: a—initiate beta-blockers treatment at a low dose; b—performing a electrocardiogram (ECG) verification of good tolerability; c—increase of beta-blockers dose only if results in step b) are satisfying.
    Type: Application
    Filed: November 22, 2013
    Publication date: March 27, 2014
    Applicant: Sanofi
    Inventor: Davide RADZIK
  • Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
    Patent number: 8602215
    Abstract: The disclosure relates to a method for managing the risk of dronedarone/beta-blockers interaction by using dronedarone or pharmaceutically acceptable salts thereof in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL), with a recent episode of AF/AFL and associated cardiovascular risk factors, who are in sinus rhythm or who will be cardioverted to reduce the risk of cardiovascular hospitalization, said patients also expecting to receive a beta-blockers treatment, by performing the following steps: a—initiate beta-blockers treatment at a low dose; b—performing a electrocardiogram (ECG) verification of good tolerability; c—increase of beta-blockers dose only if results in step b) are satisfying.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: December 10, 2013
    Assignee: Sanofi
    Inventor: Davide Radzik
  • USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR THE PREPARATION OF A DRUG FOR THE PREVENTION OF ATRIAL FIBRILLATION
    Publication number: 20130116586
    Abstract: The present invention relates to the use of dronedarone or a pharmaceutically acceptable salt thereof for the preparation of a drug for the prevention of atrial fibrillation wherein said use comprises the following precaution of use steps: a) initiating dronedarone administration in patients with atrial fibrillation or atrial flutter, b) performing electrocardiograms serially.
    Type: Application
    Filed: July 3, 2012
    Publication date: May 9, 2013
    Applicant: SANOFI
    Inventors: Lydie BARET-CORMEL, Paul Chew, Richard Gurai, Davide RADZIK, Antonio Tataranni, Estelle WEINLING
  • Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
    Patent number: 8410167
    Abstract: Methods of using dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality, articles of manufacture and packages related thereto.
    Type: Grant
    Filed: April 16, 2009
    Date of Patent: April 2, 2013
    Assignee: SANOFI
    Inventors: Davide Radzik, Martin Van Eickels, Nacéra Hamdani, Christophe Gaudin
  • USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR THE PREPARATION OF A MEDICAMENT FOR ADMINISTRATION SHORTLY AFTER AMIODARONE DISCONTINUATION
    Publication number: 20120329867
    Abstract: The present invention concerns the use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the prevention and/or treatment of patients with atrial fibrillation (AF) or atrial Flutter (AFL), shortly after discontinuation of a previous treatment with amiodarone.
    Type: Application
    Filed: September 6, 2012
    Publication date: December 27, 2012
    Applicant: SANOFI
    Inventors: Christophe GAUDIN, Ihsen Merioua, Davide RADZIK
  • METHODS FOR REDUCING THE RISK OF AN ADVERSE DRONEDARONE / BETA-BLOCKERS INTERACTION IN A PATIENT SUFFERING FROM ATRIAL FIBRILATION
    Publication number: 20120000806
    Abstract: The disclosure relates to a method for managing the risk of dronedarone/beta-blockers interaction by using dronedarone or pharmaceutically acceptable salts thereof in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL), with a recent episode of AF/AFL and associated cardiovascular risk factors, who are in sinus rhythm or who will be cardioverted to reduce the risk of cardiovascular hospitalization, said patients also expecting to receive a beta-blockers treatment, by performing the following steps: a—initiate beta-blockers treatment at a low dose; b—performing a electrocardiogram (ECG) verification of good tolerability; c—increase of beta-blockers dose only if results in step b) are satisfying.
    Type: Application
    Filed: June 30, 2011
    Publication date: January 5, 2012
    Applicant: SANOFI
    Inventor: Davide Radzik
  • METHODS FOR REDUCING THE RISK OF AN ADVERSE DRONEDARONE / CALCIUM CHANNEL BLOCKERS INTERACTION IN A PATIENT SUFFERING FROM ATRIAL FIBRILATION
    Publication number: 20120005128
    Abstract: The disclosure relates to a method for managing the risk of dronedarone/calcium channel blockers interaction by using dronedarone or pharmaceutically acceptable salts thereof in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL), with a recent episode of AF/AFL and associated cardiovascular risk factors, who are in sinus rhythm or who will be cardioverted to reduce the risk of cardiovascular hospitalization, said patients also expecting to receive a calcium channel blockers treatment, by performing the following steps: a—initiate calcium channel blockers treatment at a low dose; b—performing a electrocardiogram (ECG) verification of good tolerability; c—increase of calcium channel blockers dose only if results in step b) are satisfying.
    Type: Application
    Filed: June 29, 2011
    Publication date: January 5, 2012
    Applicant: sanofi
    Inventors: Christine GAUD, Davide RADZIK
  • USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OF STROKE OR TRANSIENT ISCHEMIC ATTACK
    Publication number: 20110230552
    Abstract: Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack.
    Type: Application
    Filed: February 4, 2011
    Publication date: September 22, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Christophe GAUDIN, Nacéra HAMDANI, Davide RADZIK, Martin VAN EICKELS
  • USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY
    Publication number: 20110224293
    Abstract: Methods of using dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality, articles of manufacture and packages related thereto.
    Type: Application
    Filed: November 22, 2010
    Publication date: September 15, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Davide RADZIK, Martin VAN EICKELS, Nacéra HAMDANI, Christophe GAUDIN
  • USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY
    Publication number: 20110213027
    Abstract: Methods of using dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality, articles of manufacture and packages related thereto.
    Type: Application
    Filed: November 22, 2010
    Publication date: September 1, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Davide RADZIK, Martin VAN EICKELS, Nacéra HAMDANI, Christophe GAUDIN
  • USE OF CELIVARONE FOR REDUCING OCCURRENCES OF CARDIOVASCULAR HOSPITALIZATION
    Publication number: 20110207811
    Abstract: The invention relates to a method of reducing occurrences of cardiovascular hospitalization of a patient by administering to the patient a pharmaceutically effective dose of the compound celivarone, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 16, 2011
    Publication date: August 25, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Christophe GAUDIN, Davide RADZIK
  • DRONEDARONE FOR THE PREVENTION OF PERMANENT ATRIAL FIBRILLATION
    Publication number: 20110166220
    Abstract: Methods of using dronedarone in the prevention of permanent atrial fibrillation.
    Type: Application
    Filed: December 7, 2010
    Publication date: July 7, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Christophe GAUDIN, Nacera HAMDANI, Davide RADZIK, Martin VAN EICKELS
  • USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVERSION
    Publication number: 20110166221
    Abstract: Methods of using dronedarone in the prevention of cardioversion.
    Type: Application
    Filed: December 7, 2010
    Publication date: July 7, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Christophe GAUDIN, Nacera HAMDANI, Davide RADZIK, Martin VAN EICKELS
  • COMBINATION OF DRONEDARONE WITH AT LEAST ONE DIURETIC, AND THERAPEUTIC USE THEREOF
    Publication number: 20110136899
    Abstract: The disclosure relates to a combination of dronedarone or a pharmaceutically salt thereof with at least one diuretic, and to the therapeutic use thereof.
    Type: Application
    Filed: October 13, 2010
    Publication date: June 9, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Davide RADZIK, Martin VAN EICKELS
  • USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR THE PREPARATION OF A MEDICAMENT FOR REGULATING THE POTASIUM LEVEL IN THE BLOOD
    Publication number: 20110124724
    Abstract: Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in regulating the potassium level in the blood.
    Type: Application
    Filed: October 13, 2010
    Publication date: May 26, 2011
    Applicant: SANOFI-AVENTIS
    Inventors: Christophe GAUDIN, Nacera HAMDANI, Davide RADZIK, Martin VAN EICKELS